Joel Stanley is the Chief Executive Officer of AJNA BioSciences, a botanical drug development company pioneering FDA-approved therapies derived from medicinal plants and fungi. Founded in 2020, AJNA is focused on transforming natural compounds into clinically validated treatments for conditions such as anxiety and autism spectrum disorder.

Joel Stanley is the Chief Executive Officer of AJNA BioSciences, a botanical drug development company pioneering FDA-approved therapies derived from medicinal plants and fungi. Founded in 2020, AJNA is focused on transforming natural compounds into clinically validated treatments for conditions such as anxiety and autism spectrum disorder.

Previously, Joel was the co-founder, CEO, and later Chairman of Charlotte’s Web, the pioneering CBD company inspired by his work with Charlotte Figi. His efforts helped catalyze a global movement around cannabis-based wellness and reshape public perception of plant-based medicine.

Joel also serves on the board of Stanley Brothers, continuing to advance plant science innovation. Based in Denver, he is committed to merging rigorous science with the healing power of nature to develop accessible, evidence-based natural medicines.